PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER
申请人:Buhr Chris A.
公开号:US20100150827A1
公开(公告)日:2010-06-17
The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer.
PYRIDO [2, 3-D]PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER
申请人:Exelixis, Inc.
公开号:EP2142543A1
公开(公告)日:2010-01-13
[EN] PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF PI3K-ALPHA FOR THE TREATMENT OF CANCER<br/>[FR] COMPOSÉS PYRIDO [2, 3-D] PYRIMIDIN-7-ONE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-ALPHA POUR LE TRAITEMENT DU CANCER
申请人:EXELIXIS INC
公开号:WO2008127678A1
公开(公告)日:2008-10-23
[EN] The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer. [FR] L'invention concerne un composé de formule I, II, ou III. Les composés de l'invention inhibent, régulent et/ou modulent l'activité de PI3K et sont utiles dans le traitement de maladies hyperprolifératives, comme le cancer.